Phase III data show Dupixent reduced itch in chronic spontaneous urticaria patients
February 28, 2022Sales and Marketing
Results from a Phase III trial have revealed that adding Dupixent (dupilumab) to standard-of-care antihistamines significanty reduced itch and hives …
Urgent need to address mental health crisis among kidney patients
February 28, 2022Sales and Marketing
Kidney Research UK has released their findings from a survey of 1,000 kidney disease patients in the UK, revealing the …
Kapruvia receives positive CHMP opinion for pruritus in hemodialysis patients
February 28, 2022Sales and Marketing
The CHMP has approved Kapruvia (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in hemodialysis patients. …
Study reveals potential genetic determinants of unexplained child deaths
February 25, 2022Medical Communications
Various genetic determinants may cause a predisposition to Sudden Unexpected Death in Paediatrics (SUPD), which encompasses syndromes such as Sudden …
NICE draft guidance recommends tucatinib for advanced breast cancer
February 25, 2022Medical Communications
Roughly 400 people with advanced breast cancer are set to benefit from a new treatment, following the NICE publication of …
CHMP recommends QUVIVIQ in Europe as a new treatment for adult insomnia patients
February 25, 2022Medical Communications
The CHMP has adopted a positive opinion for the use of QUVIVIQ for the treatment of adult patients with insomnia. …
Plant-based COVID-19 vaccine approved
February 25, 2022Medical Communications
Medicago and GlaxoSmithKline (GSK) have announced the approval by Health Canada of COVIFENZ®, a COVID-19 vaccine manufactured in plants, with …
South Korea approves Pfizer vaccine for children aged 5-11
February 24, 2022Business Services
South Korea’s drug safety agency on authorised the use of Pfizer’s COVID-19 vaccine on 23 February, for children aged between …
CDC: some should wait longer for second COVID-19 vaccination
February 24, 2022Business Services
The CDC updated its vaccine guidance for COVID-19, recommending that some American over the age of 12 who have received …
New sickle cell treatment administered to first patients in England
February 24, 2022Business Services
Sickle cell patients have now begun receiving the first new treatment for the blood disorder in over 20 years. The …
NICE recommends GSK’s ZEJULA (niraparib) for ovarian cancer patients
February 24, 2022Business Services
NICE has issued a Final Appraisal Determination (FAD), recommending the use of ZEJULA (niraparib) on the NHS. Niraparib is recommended …
93% accuracy in new Alzheimer’s test, according to international study
February 23, 2022Research and Development
The Washington University School of Medicine in St Louis has developed a blood test for Alzheimer’s disease which has proved …
Extra blood test could help detect risk of death from heart attack
February 23, 2022Research and Development
Researchers say that an extra blood test on suspected heart-attack patients could determine if they are at high risk of …
FDA places gene therapy trial on hold
February 23, 2022Research and Development
Homology Medicines has shared that the FDA has placed its pheNIX gene therapy trial of HMI-102 in adults with phenylketonuria …
NICE recommends Albireo’s Bylvay (odevixibat) for all PFIC types
February 23, 2022Research and Development
NICE has issued guidance that recommends Bylvay (odevixibat) for the treatment of all types of progressive familial intrahepatic cholestasis (PFIC) …
FDA grants approval for expanded indication of heart failure sensor
February 22, 2022Manufacturing and Production
The FDA has granted approval for an expanded indication of Abbott’s CardioMEMS HF System, a small implantable sensor that can …
NovoBiome and Inserm begin collaboration into human intestinal physiology
February 22, 2022Manufacturing and Production
NovoBiome, a drug discovery company developing breakthrough Live Biotherapeutics Products, announced that it has signed a new collaboration with the …
UK to offer extra COVID-19 booster for over-75s and high risk in spring
February 22, 2022Manufacturing and Production
An additional booster dose will be offered to all adults over-75, as well as the most vulnerable over-12s, in the …
Apollo Therapeutics and King’s College London collaborate for translational biology and drug development
February 22, 2022Manufacturing and Production
Apollo Therapeutics has expanded its partnerships with world-leading UK research institutions, entering into a strategic collaboration with King’s College, London. …
CanSinoBIO’s Convidecia approved as heterologous COVID-19 booster in China
February 21, 2022Sales and Marketing
CanSino Biologics announced that its recombinant novel coronavirus vaccine has been approved by the Joint Prevention and Control Mechanism of …
Latest content
